AMRC Open Research is a new platform for rapid author-led publication and open peer review of research funded by AMRC member charities.
Epilepsy Research UK is one of 23 members of the Association of Medical Research Charities (AMRC) working in collaboration to develop and launch a joint publication platform, AMRC Open Research. By removing traditional barriers and delays to publication, the new platform will help charities maximise the value of the donations they receive by making it possible for every output from the research they fund to be rapidly and openly shared.By making articles available in a matter of days, rather than the typical months or years that traditional publishing can take, and by including access to the raw data, AMRC Open Research will help accelerate our understanding of conditions and diseases that affect so many lives, including epilepsy.All articles on AMRC Open Research will be published as open access enabling anyone to see the results of the research, including those living with or affected by the conditions being researched, the charities’ wider communities and the public. The expert peer review reports will also be posted alongside the articles, helping everyone understand the merit of the published work about health conditions and diseases.AMRC Open Research will provide a new publication option for researchers funded by ERUK that gives them increased control over the process. As long as the researchers meet eligibility criteria, no editorial decisions are made based on the topic, perceived impact or outcome of their articles. This enables them to openly and immediately share all results from their funded research with the scientific community and beyond. Once published, articles will undergo invited open peer review by experts in the respective field.Bruno Frenguelli, the chair of ERUK’s Scientific Advisory Committee, said: “This initiative by AMRC provides another way in which ERUK-funded researchers can share the results of their studies with everyone, and not just those in institutions who pay for subscriptions to scientific or medical journals. The emphasis on peer-review is important so that readers can be assured as to the quality and value of the work. The platform also allows negative results to be published, which may avoid unnecessary replication of those studies by others, allowing valuable and often limited resources to be used in more fruitful lines of investigation.”The 23 participating charities are: Alzheimer’s Research UK, Ataxia UK, Autistica, BRACE, Children’s Cancer and Leukaemia Group, Epilepsy Research UK, Macmillan Cancer Support, Meningitis Research Foundation, MQ: Transforming Mental Health, Multiple Sclerosis Society, National Eye Research Centre, National Osteoporosis Society, Pancreatic Cancer UK, Parkinson’s UK, Pharmacy Research UK, Royal Hospital for Neuro-disability, Spinal Research, Stroke Association, Target Ovarian Cancer, The Brain Tumour Charity, The Cure Parkinson’s Trust, The Lullaby Trust, and The Scar Free Foundation